• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

树突状细胞负载肝癌源性 RNA 或细胞裂解物诱导的细胞毒性 T 淋巴细胞反应的比较分析。

Comparative analysis of cytotoxic T lymphocyte response induced by dendritic cells loaded with hepatocellular carcinoma -derived RNA or cell lysate.

机构信息

State Key Laboratory of Oncology in Southern China and Department of Experimental Research, Cancer Center, Sun Yat-sen University, Guangzhou 510060, PR China.

出版信息

Int J Biol Sci. 2010 Oct 13;6(7):639-48. doi: 10.7150/ijbs.6.639.

DOI:10.7150/ijbs.6.639
PMID:20975822
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2962266/
Abstract

The choice of the tumor antigen preparation used for dendritic cell (DC) loading is important for optimizing DC vaccines. In the present study, we compared DCs pulsed with hepatocellular carcinoma (HCC) total RNA or cell lysates for their capacity to activate T cells. We showed here that HCC total RNA pulsed-DCs induced effector T lymphocyte responses which showed higher killing ability to HCC cell lines, as well as higher frequency of IFN-γ producing of CD4+ and CD8+ T cells when compared with lysate pulsed-DCs. Both of RNA and lysate loading did not influence the changes of mature DC phenotype and the capacity of inducing T cell proliferation. However, HCC lysate loading significantly inhibited the production of inflammatory cytokines IL-12p70, IFN-γ and enhanced the secretion of anti-inflammatory cytokines IL-10 of mature DCs. Our results indicated that DCs loaded with HCC RNA are superior to that loaded with lysate in priming anti-HCC CTL response, suggesting that total RNA may be a better choice for DCs-based HCC immunotherapy.

摘要

用于树突状细胞 (DC) 加载的肿瘤抗原制剂的选择对于优化 DC 疫苗很重要。在本研究中,我们比较了用肝癌 (HCC) 总 RNA 或细胞裂解物脉冲处理的 DC 激活 T 细胞的能力。我们在这里表明,与用裂解物脉冲处理的 DC 相比,用 HCC 总 RNA 脉冲处理的 DC 诱导的效应 T 淋巴细胞反应显示出更高的杀伤 HCC 细胞系的能力,以及更高频率的 IFN-γ 产生的 CD4+和 CD8+T 细胞。RNA 和裂解物加载都不会影响成熟 DC 表型的变化和诱导 T 细胞增殖的能力。然而,HCC 裂解物加载显著抑制了成熟 DC 中炎症细胞因子 IL-12p70、IFN-γ 的产生,并增强了抗炎细胞因子 IL-10 的分泌。我们的结果表明,负载 HCC RNA 的 DC 在启动抗 HCC CTL 反应方面优于负载裂解物的 DC,这表明总 RNA 可能是基于 DC 的 HCC 免疫治疗的更好选择。

相似文献

1
Comparative analysis of cytotoxic T lymphocyte response induced by dendritic cells loaded with hepatocellular carcinoma -derived RNA or cell lysate.树突状细胞负载肝癌源性 RNA 或细胞裂解物诱导的细胞毒性 T 淋巴细胞反应的比较分析。
Int J Biol Sci. 2010 Oct 13;6(7):639-48. doi: 10.7150/ijbs.6.639.
2
Antigen-loaded dendritic cells triggers a specific cytotoxic T lymphocytes immune response against hepatocellular carcinoma: in vitro study.负载抗原的树突状细胞引发针对肝细胞癌的特异性细胞毒性 T 淋巴细胞免疫应答:体外研究。
Clin Transl Oncol. 2019 May;21(5):636-645. doi: 10.1007/s12094-018-1965-6. Epub 2018 Oct 27.
3
Tumor cell lysate-pulsed human dendritic cells induce a T-cell response against pancreatic carcinoma cells: an in vitro model for the assessment of tumor vaccines.肿瘤细胞裂解物脉冲处理的人树突状细胞诱导针对胰腺癌细胞的T细胞反应:一种评估肿瘤疫苗的体外模型。
Cancer Res. 2001 Sep 1;61(17):6445-50.
4
[An in vitro study of specific antitumor immunity induced by dendritic cells pulsed with tumor cell lysates from patients with hepatocellular carcinoma].[树突状细胞负载肝癌患者肿瘤细胞裂解物诱导特异性抗肿瘤免疫的体外研究]
Zhonghua Gan Zang Bing Za Zhi. 2005 Mar;13(3):198-201.
5
Administration of interleukin-12 enhances the therapeutic efficacy of dendritic cell-based tumor vaccines in mouse hepatocellular carcinoma.白细胞介素-12的给药增强了基于树突状细胞的肿瘤疫苗对小鼠肝细胞癌的治疗效果。
Cancer Res. 2001 Oct 15;61(20):7563-7.
6
alpha-fetoprotein and interleukin-18 gene-modified dendritic cells effectively stimulate specific type-1 CD4- and CD8-mediated T-Cell response from hepatocellular carcinoma patients in Vitro.甲胎蛋白和白细胞介素-18基因修饰的树突状细胞在体外能有效刺激肝癌患者产生特异性1型CD4和CD8介导的T细胞应答。
Hum Immunol. 2007 May;68(5):334-41. doi: 10.1016/j.humimm.2007.01.008. Epub 2007 Feb 21.
7
Strategies for antigen choice and priming of dendritic cells influence the polarization and efficacy of antitumor T-cell responses in dendritic cell-based cancer vaccination.在基于树突状细胞的癌症疫苗接种中,树突状细胞的抗原选择和启动策略会影响抗肿瘤T细胞反应的极化和效力。
Cancer Immunol Immunother. 2004 Nov;53(11):963-77. doi: 10.1007/s00262-004-0542-8. Epub 2004 May 14.
8
NKT and CD8 lymphocytes mediate suppression of hepatocellular carcinoma growth via tumor antigen-pulsed dendritic cells.自然杀伤T细胞和CD8淋巴细胞通过肿瘤抗原负载的树突状细胞介导对肝细胞癌生长的抑制。
Int J Cancer. 2003 Aug 20;106(2):236-43. doi: 10.1002/ijc.11201.
9
Dendritic cells engineered to secrete anti-DcR3 antibody augment cytotoxic T lymphocyte response against pancreatic cancer .经基因工程改造以分泌抗DcR3抗体的树突状细胞增强了针对胰腺癌的细胞毒性T淋巴细胞反应。
World J Gastroenterol. 2017 Feb 7;23(5):817-829. doi: 10.3748/wjg.v23.i5.817.
10
Antigen-specific T cell response from dendritic cell vaccination using side population cell-associated antigens targets hepatocellular carcinoma.使用侧群细胞相关抗原进行树突状细胞疫苗接种产生的抗原特异性T细胞反应靶向肝细胞癌。
Tumour Biol. 2016 Aug;37(8):11267-78. doi: 10.1007/s13277-016-4935-z. Epub 2016 Mar 7.

引用本文的文献

1
Research Progress on Dendritic Cells in Hepatocellular Carcinoma Immune Microenvironments.肝细胞癌免疫微环境中树突状细胞的研究进展。
Biomolecules. 2024 Sep 16;14(9):1161. doi: 10.3390/biom14091161.
2
Dendritic cells loaded with CD44 CT-26 colon cell lysate evoke potent antitumor immune responses.负载CD44 CT-26结肠癌细胞裂解物的树突状细胞可引发强烈的抗肿瘤免疫反应。
Oncol Lett. 2019 Dec;18(6):5897-5904. doi: 10.3892/ol.2019.10952. Epub 2019 Oct 2.
3
Cytolytic Activity of Effector T-lymphocytes Against Hepatocellular Carcinoma is Improved by Dendritic Cells Pulsed with Pooled Tumor Antigens.

本文引用的文献

1
RNA-based immunotherapy of cancer: role and therapeutic implications of dendritic cells.基于RNA的癌症免疫疗法:树突状细胞的作用及治疗意义
Expert Rev Anticancer Ther. 2009 Jan;9(1):97-114. doi: 10.1586/14737140.9.1.97.
2
A phase II study of adoptive immunotherapy using dendritic cells pulsed with tumor lysate in patients with hepatocellular carcinoma.一项使用肿瘤裂解物脉冲处理的树突状细胞进行过继性免疫治疗肝细胞癌患者的II期研究。
Hepatology. 2009 Jan;49(1):124-32. doi: 10.1002/hep.22626.
3
The dysfunction and abnormal signaling pathway of dendritic cells loaded by tumor antigen can be overcome by neutralizing VEGF in multiple myeloma.
树突状细胞负载肿瘤抗原对效应 T 淋巴细胞杀伤肝癌细胞活性的影响
Sci Rep. 2019 Nov 27;9(1):17668. doi: 10.1038/s41598-019-54087-0.
4
Antigen-specific T cell response from dendritic cell vaccination using side population cell-associated antigens targets hepatocellular carcinoma.使用侧群细胞相关抗原进行树突状细胞疫苗接种产生的抗原特异性T细胞反应靶向肝细胞癌。
Tumour Biol. 2016 Aug;37(8):11267-78. doi: 10.1007/s13277-016-4935-z. Epub 2016 Mar 7.
5
Prophylactic Dendritic Cell-Based Vaccines Efficiently Inhibit Metastases in Murine Metastatic Melanoma.基于树突状细胞的预防性疫苗可有效抑制小鼠转移性黑色素瘤的转移。
PLoS One. 2015 Sep 1;10(9):e0136911. doi: 10.1371/journal.pone.0136911. eCollection 2015.
6
Clinical trials of dendritic cell-based cancer vaccines in hematologic malignancies.基于树突状细胞的癌症疫苗在血液系统恶性肿瘤中的临床试验。
Hum Vaccin Immunother. 2014;10(11):3125-31. doi: 10.4161/21645515.2014.982993.
7
Antigen-loaded dendritic cell migration: MR imaging in a pancreatic carcinoma model.负载抗原的树突状细胞迁移:胰腺癌模型中的磁共振成像
Radiology. 2015 Jan;274(1):192-200. doi: 10.1148/radiol.14132172. Epub 2014 Sep 15.
8
Evaluation of RNA Amplification Methods to Improve DC Immunotherapy Antigen Presentation and Immune Response.评估 RNA 扩增方法以提高 DC 免疫治疗中的抗原呈递和免疫应答。
Mol Ther Nucleic Acids. 2013 May 7;2(5):e91. doi: 10.1038/mtna.2013.18.
9
Progression of chronic liver inflammation and fibrosis driven by activation of c-JUN signaling in Sirt6 mutant mice.Sirt6 突变小鼠中 c-JUN 信号激活驱动的慢性肝炎症和纤维化的进展。
J Biol Chem. 2012 Dec 7;287(50):41903-13. doi: 10.1074/jbc.M112.415182. Epub 2012 Oct 16.
在多发性骨髓瘤中,通过中和血管内皮生长因子(VEGF)可克服肿瘤抗原负载的树突状细胞的功能障碍和异常信号通路。
Leuk Res. 2009 May;33(5):665-70. doi: 10.1016/j.leukres.2008.09.006. Epub 2008 Oct 15.
4
Optimization of dendritic cell loading with tumor cell lysates for cancer immunotherapy.用于癌症免疫治疗的肿瘤细胞裂解物负载树突状细胞的优化。
J Immunother. 2008 Sep;31(7):620-32. doi: 10.1097/CJI.0b013e31818213df.
5
Tumour-mediated disruption of dendritic cell function: inhibiting the MEK1/2-p44/42 axis restores IL-12 production and Th1-generation.肿瘤介导的树突状细胞功能破坏:抑制MEK1/2-p44/42轴可恢复IL-12产生和Th1细胞生成。
Int J Cancer. 2008 Aug 1;123(3):623-32. doi: 10.1002/ijc.23530.
6
Immunological decision-making: how does the immune system decide to mount a helper T-cell response?免疫决策:免疫系统如何决定引发辅助性T细胞反应?
Immunology. 2008 Mar;123(3):326-38. doi: 10.1111/j.1365-2567.2007.02719.x. Epub 2007 Nov 5.
7
Taming cancer by inducing immunity via dendritic cells.通过树突状细胞诱导免疫来控制癌症。
Immunol Rev. 2007 Dec;220:129-50. doi: 10.1111/j.1600-065X.2007.00575.x.
8
DC-based cancer vaccines.基于树突状细胞的癌症疫苗。
J Clin Invest. 2007 May;117(5):1195-203. doi: 10.1172/JCI31205.
9
Immunologic and clinical effects of injecting mature peptide-loaded dendritic cells by intralymphatic and intranodal routes in metastatic melanoma patients.通过淋巴管内和淋巴结内途径注射负载成熟肽的树突状细胞对转移性黑色素瘤患者的免疫和临床影响。
Clin Cancer Res. 2006 Dec 15;12(24):7380-8. doi: 10.1158/1078-0432.CCR-06-1879.
10
Immunologic and clinical responses after vaccinations with peptide-pulsed dendritic cells in metastatic renal cancer patients.转移性肾癌患者接种肽脉冲树突状细胞后的免疫和临床反应。
Cancer Res. 2006 Jun 1;66(11):5910-8. doi: 10.1158/0008-5472.CAN-05-3905.